Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo
As a novel acid-suppressing drug, vonoprazan shows the potential to replace traditional proton-pump inhibitors. With its widespread use, some adverse effects that require further study have emerged due to drug-drug interactions. Our study is the first experiment that evaluated the drug-drug interact...
Saved in:
Main Authors: | Yiran Wang (Author), Jihua Shi (Author), Dapeng Dai (Author), Jianping Cai (Author), Shuanghu Wang (Author), Yun Hong (Author), Shan Zhou (Author), Fangling Zhao (Author), Quan Zhou (Author), Peiwu Geng (Author), Yunfang Zhou (Author), Xue Xu (Author), Qingfeng Luo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
by: Yiran Wang, et al.
Published: (2020) -
Effects of bergapten on the pharmacokinetics of macitentan in rats both in vitro and in vivo
by: Jia Xu, et al.
Published: (2023) -
Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo
by: Hong Y, et al.
Published: (2022) -
Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo
by: Shan Zhou, et al.
Published: (2023) -
Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
by: Jinhui Wang, et al.
Published: (2021)